Roger L Nation

7PUBLICATIONS
21CO-AUTHORS
Toxicology (incl. clinical toxicology)Medical bacteriologyPharmacogenomicsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity.

Patrick O Hanafin, Ramya Mahadevan, Gauri G Rao

|Sep 30, 2024
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.

Stephanie L Rolsma, Andrew Sokolow, Pratish C Patel

|Apr 18, 2023
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.

Guohua An, C Buddy Creech, Nan Wu

|Apr 26, 2022
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.

Jessica R Tait, Timothy C Barnett, Kate E Rogers

|Jan 29, 2021
Cure of Limb-Threatening XDR Pseudomonas aeruginosa Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement.

Shanti Narayanasamy, Roger L Nation, Andrew A Mahony

|Jul 10, 2019
Optimization of dosing regimens of intravenous colistin in patients with cystic fibrosis: What data are required?

Roger L Nation, Cornelia B Landersdorfer

Pageof 2

Frequent Collaborators

4 joint publications

Cornelia B Landersdorfer

2 joint publications

Jian Li

2 joint publications

Guohua An

2 joint publications

Stephanie Rolsma